XML 78 R65.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies - Legal Proceedings (Details)
$ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
lawsuit
Dec. 31, 2025
USD ($)
Loss Contingencies [Line Items]    
Litigation settlement liability $ 950  
Finite-lived intangible assets, net 116 $ 45
Arbutus Biopharma Corporation (Arbutus) and Genevant Sciences GmbH (Genevant)    
Loss Contingencies [Line Items]    
Litigation settlement liability 950  
Amount awarded to other party 876  
Loss contingency, estimate of possible loss 74  
Arbutus Biopharma Corporation (Arbutus) and Genevant Sciences GmbH (Genevant) | Maximum    
Loss Contingencies [Line Items]    
Litigation liability $ 1,300  
Arbutus Biopharma Corporation (Arbutus) and Genevant Sciences GmbH (Genevant) | Intellectual Property    
Loss Contingencies [Line Items]    
Finite-lived intangible asset, useful life 3 years  
Finite-lived intangible assets, net $ 72  
GlaxoSmithKline Biologicals    
Loss Contingencies [Line Items]    
Number of patent infringement cases | lawsuit 2